Nemo Despot Marjanovic

Nemo (Nemanja) Despot Marjanovic is a highly experienced financial analyst currently working at ARK Investment Management LLC since November 2023, focusing on investments intersecting engineering, Big Data, and AI, primarily in the healthcare sector. Prior positions include Senior Associate at Northpond Ventures and Associate at Third Rock Ventures, where responsibilities centered on discovering and launching biotechnology companies through thorough due diligence. Academic experience includes a PhD candidacy in Aviv Regev Lab at the Broad Institute of MIT and Harvard, investigating single-cell RNA-seq methods related to tumor development and treatment resistance. Additional research roles involved the MIT Koch Institute for Integrative Cancer Research, Flagship Pioneering, and the Whitehead Institute, contributing to cancer therapeutics and the study of cancer stem cells. Nemo holds a PhD in engineering and a master’s in experimental biomedicine from the Massachusetts Institute of Technology, as well as a master’s in molecular biology from the University of Belgrade.